Such chimeric viruses induce an immune response against NDV and the infectious agent.

Attenuated respiratory syncytial viruses (RSV) and in particular temperature sensitive RSV are provided.

Replication-defective viruses and means for intracellular replication thereof are described which are useful for gene therapy.

Such chimeric viruses induce an immune response against influenza virus and the infectious agent.

The present invention provides chimeric primary viruses, which are capable of producing secondary viruses in a producer host cell, and methods of making the same.

Intact hepatitis C virus (HCV) particles, purified HCV proteins, and glycopeptide antigens specific to HCV particles are disclosed.

The invention relates to the field of paramyxoviridae, vaccines against infections by such viruses, diagnostics for detecting such viruses and targets for therapeutics against such viruses.

Also described herein are recombinant influenza viruses comprising a modified influenza virus NS gene segment and the use of such viruses.

Methods for making such inactivated viruses, bacteria, fungi, parasites and tumor cells are also provided.

Furthermore, the invention relates to vaccines based upon such Bovine Respiratory Syncytial Viruses and to methods for the preparation of such vaccines.

Attenuated respiratory syncytial viruses (RSV) and in particular temperature sensitive RSV are provided.

Such viruses include canine adenovirus, reovirus and the canine herpes virus.

The present invention relates to vaccines against AIDS-like viruses comprising antibodies and their equivalents specific for such viruses or cellular receptors therefor, and to methods of treatment and prophylaxis using such vaccines.

The present application is directed to methods of inhibiting or preventing infection of a mammal by a measles virus and a respiratory syncytial virus, as well as methods of inactivating such viruses.

Such viruses are useful for vaccinations and for treating cancer patients as the viruses are not shed.